Your Health Plan:
Your Health Plan:
Not SelectedULTOMIRIS (ravulizumab) is a biologic prescription drug for treatment of Paroxysmal nocturnal hemoglobinuria, Atypical Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, Thrombotic Microangiopathies and Myasthenia Gravis, Generalized. ULTOMIRIS is a complement inhibitor. It is available in the form of intravenous solution / subcutaneous solution.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $6900-30600.
Patient Assistance Prorgams and Coupons are found:
No other option is found for ULTOMIRIS